Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany

Background: About 400,000-500,000 people are infected with hepatitis C in Germany. Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. The introduction of first generation protease inhibitors has significantly improved the treatment of hepatitis C genotype 1 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Stahmeyer, Jona T., Schauer, Svenja, Rossol, Siegbert, Heinrich Wedemeyer, Hans, Wirth, Daniel, Bianic, Florence, Krauth, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2013
Materias:
Nephrologic/Hepatologic Conditions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471398/
https://www.ncbi.nlm.nih.gov/pubmed/37662876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471398/
https://www.ncbi.nlm.nih.gov/pubmed/37662876

Ejemplares similares